Researchers have developed an approach to concentrate and encapsulate significantly higher levels of MRI-detectable gandolinium complex into apoferritin than current conventional methods.  The resulting MRI contract reagents have 3-10 times higher relaxivity than that of commercially available MRI contrast agents (data below).  

To access the rest of the information on this page,
Log In or sign up for a free B-Bridge account: